Farmakoterapia w Psychiatrii i Neurologii

Pełna treść

1/2024 vol. 40
Opis przypadku

Zatrucie litem w przebiegu stosowania antagonistów receptora angiotensyny II oraz hydrochlorotiazydu. Opis dwóch przypadków

Isabella Nizińska 1
,
Karolina Gattner 1
  1. HCP Medical Centre; Centrum Zdrowia Psychicznego HCP
Farmakoterapia w Psychiatrii i Neurologii 2024, 40 (1), 53–60
DOI: https://doi.org/10.5114/fpn.2024.141961
Data publikacji online: 2024/08/01
Plik artykułu
06_IPiN_FARM_2024-1E_Zatrucie litem.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Adityanjee. The syndrome of irreversible lithium effectuated neurotoxicity. J Neurol Neurosurg Psychiatry. 1987; 50(9): 1246–7.
  2. Baird-Gunning J, Lea-Henry T, Hoegberg LCG, Gosselin S, Roberts DM. Lithium Poisoning. J Intensive Care Med 2017; 32(4): 249–63.
  3. Bisogni V, Rossitto G, Reghin F, Padrini R, Rossi GP. Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders. J Hypertens 2016; 34 (1): 20–8.
  4. Edokpolo O, Fyyaz M. Lithium toxicity and neurologic effects: probable neuroleptic malignant syndrome resulting from lithium toxicity. Case Rep Psychiatry 2012; 2012: 271858. doi:10.1155/2012/271858.
  5. Finley PR, O’Brien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharmacol 1996; 16(1): 68–71.
  6. Lazarczyk MJ, Giannakopoulos P. Temporal association as a prerequisite factor of valsartan-induced lithium toxicity. Bipolar Disord 2014; 16(6): 662–6.
  7. Leung M, Remick RA. Potential drug interaction between lithium and valsartan. J Clin Psychopharmacol 2000; 20(3): 392–3.
  8. Meyer JM, Dollarhide A, Tuan IL. Lithium toxicity after switch from fosinopril to lisinopril. Int Clin Psychopharmacol 2005; 20(2): 115–118.
  9. Momoniat T, Ilyas D, Bhandari S. ACE inhibitors and ARBs: Managing potassium and renal function. Cleve Clin J Med 2019; 86 (9): 601–607.
  10. Ott M, Stegmayr B, Salander Renberg E, Werneke U. Lithium intoxication: Incidence, clinical course and renal function – a population-based retrospective cohort study. J Psychopharmacol 2016; 30 (10): 1008–1019.
  11. Rybakowski J. Lit. Niezwykły lek w psychiatrii. Termedia Wydawnictwa Medyczne, wyd. 1, Poznań 2019.
  12. Rybakowski J. Psychofarmakologia kliniczna. Wydawnictwo Lekarskie PZWL, wyd. 1, Warszawa 2022.
  13. Scherf-Clavel M, Treiber S, Deckert J, Unterecker S, Hommers L. Drug-Drug Interactions Between Lithium and Cardiovascular as Well as Anti-Inflammatory Drugs. Pharmacopsychiatry 2020; 53(5): 229–234.
  14. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging 2000; 16(3): 165–177.
  15. Su YP, Chang CJ, Hwang TJ. Lithium intoxication after valsartan treatment. Psychiatry Clin Neurosci. 2007; 61(2): 204.
  16. Tursun I, Tazegul G, Karhan O, et al. Polypharmacy May Be the Cause of Acute Lithium Intoxication at the Second Day of Treatment. Folia Med (Plovdiv) 2015; 57(3–4): 261–263.
  17. Wilting I, Movig KL, Moolenaar M, et al. Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice. Bipolar Disord 2005; 7(3): 274–280.
  18. Zwanzger P, Marcuse A, Boerner RJ, Walther A, Rupprecht R. Lithium intoxication after administration of AT1 blockers. J Clin Psychiatry 2001; 62(3): 208–20
ZGŁASZANIE PRAC
Udostępnij
without publication fees
without publication fees
Zintergrowane z
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications